• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经脊髓炎患者的血清会破坏血脑屏障。

Sera from neuromyelitis optica patients disrupt the blood-brain barrier.

机构信息

Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.

出版信息

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):288-97. doi: 10.1136/jnnp-2011-300434. Epub 2011 Nov 19.

DOI:10.1136/jnnp-2011-300434
PMID:22100760
Abstract

OBJECTIVE

In neuromyelitis optica (NMO), the destruction of the blood-brain barrier (BBB) has been considered to be the first step of the disease process. It is unclear whether sera from patients with NMO can open the BBB, and which component of patient sera is most important for this disruption.

METHODS

The effects of sera from antiaquaporin4 (AQP4) antibody positive NMO patients, multiple sclerosis patients and control subjects were evaluated for expression of tight junction proteins and for transendothelial electrical resistance (TEER) of human brain microvascular endothelial cells (BMECs). Whether antibodies against human BMECs as well as anti-AQP4 antibodies exist in NMO sera was also examined using western blot analysis.

RESULTS

Expression of tight junction proteins and TEER in BMECs was significantly decreased after exposure to NMO sera. However, this effect was reversed after application of an antivascular endothelial growth factor (VEGF) neutralising antibody. Antibodies against BMECs other than anti-AQP4 antibodies were found in the sera of NMO patients whereas no specific bands were detected in the sera of healthy and neurological controls. These antibodies apparently disrupt the BBB by increasing the autocrine secretion of VEGF by BMECs themselves. Absorption of the anti-AQP4 antibody by AQP4 transfected astrocytes reduced AQP4 antibody titres but was not associated with a reduction in BBB disruption.

CONCLUSIONS

Sera from NMO patients reduce expression of tight junction proteins and disrupt the BBB. Autoantibodies against BMECs other than anti-AQP4 antibodies may disrupt the BBB through upregulation of VEGF in BMECs.

摘要

目的

在视神经脊髓炎(NMO)中,血脑屏障(BBB)的破坏被认为是疾病过程的第一步。目前尚不清楚 NMO 患者的血清是否可以打开 BBB,以及患者血清中的哪个成分对此破坏最为重要。

方法

评估抗水通道蛋白 4(AQP4)抗体阳性的 NMO 患者、多发性硬化症患者和对照者的血清对人脑血管内皮细胞(BMEC)紧密连接蛋白的表达和跨内皮电阻(TEER)的影响。还使用 Western blot 分析检查 NMO 血清中是否存在针对人 BMEC 的抗体以及抗 AQP4 抗体。

结果

暴露于 NMO 血清后,BMEC 中紧密连接蛋白的表达和 TEER 明显降低。然而,在用血管内皮生长因子(VEGF)中和抗体处理后,这种作用被逆转。在 NMO 患者的血清中发现了针对除 AQP4 抗体以外的 BMEC 的抗体,而在健康和神经对照组的血清中则未检测到特异性条带。这些抗体显然通过增加 BMEC 自身的 VEGF 的自分泌而破坏 BBB。AQP4 转染星形胶质细胞对 AQP4 抗体的吸收降低了 AQP4 抗体滴度,但与 BBB 破坏的减少无关。

结论

NMO 患者的血清降低了紧密连接蛋白的表达并破坏了 BBB。除抗 AQP4 抗体以外的针对 BMEC 的自身抗体可能通过上调 BMEC 中的 VEGF 来破坏 BBB。

相似文献

1
Sera from neuromyelitis optica patients disrupt the blood-brain barrier.视神经脊髓炎患者的血清会破坏血脑屏障。
J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):288-97. doi: 10.1136/jnnp-2011-300434. Epub 2011 Nov 19.
2
Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.自分泌 MMP-2/9 分泌增加视神经脊髓炎中的血脑屏障通透性。
J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):419-30. doi: 10.1136/jnnp-2013-305907. Epub 2013 Nov 20.
3
NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement.NMO 血清可下调人星形胶质细胞中的 AQP4,并在不依赖补体的情况下诱导细胞毒性。
J Neurol Sci. 2013 Aug 15;331(1-2):136-44. doi: 10.1016/j.jns.2013.05.035. Epub 2013 Jun 25.
4
Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.视神经脊髓炎中血脑屏障的IP-10产生显著增加。
PLoS One. 2015 Mar 26;10(3):e0122000. doi: 10.1371/journal.pone.0122000. eCollection 2015.
5
Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.葡萄糖调节蛋白78自身抗体与视神经脊髓炎中的血脑屏障破坏相关。
Sci Transl Med. 2017 Jul 5;9(397). doi: 10.1126/scitranslmed.aai9111.
6
[Disruption of blood-brain barrier in multiple sclerosis and neuromyelitis optica].[多发性硬化症和视神经脊髓炎中的血脑屏障破坏]
Nihon Rinsho. 2014 Nov;72(11):1949-54.
7
Blood-brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study.血脑屏障破坏决定 Fisher/Bickerstaff 临床表型:一项体外研究。
J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):756-65. doi: 10.1136/jnnp-2012-304306. Epub 2013 Apr 12.
8
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.根据抗水通道蛋白 4 抗体状况,日本视神经脊髓炎患者具有不同的遗传和感染特征。
J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):29-34. doi: 10.1136/jnnp-2012-302925. Epub 2012 Oct 4.
9
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.在视神经脊髓炎中,脑脊液中金属蛋白酶-2 和白细胞介素-6 的增加与白蛋白商数有关:它们对血脑屏障破坏的可能作用。
Mult Scler. 2017 Jul;23(8):1072-1084. doi: 10.1177/1352458516672015. Epub 2016 Sep 28.
10
[Disruption of the blood-brain barrier in inflammatory neurological diseases].[炎症性神经系统疾病中血脑屏障的破坏]
Brain Nerve. 2013 Feb;65(2):165-76.

引用本文的文献

1
Acute neuromyelitis optica spectrum disorder patients' clinical analysis of disability-related biomarkers.急性视神经脊髓炎谱系障碍患者残疾相关生物标志物的临床分析
BMC Neurol. 2025 Mar 20;25(1):119. doi: 10.1186/s12883-025-04086-8.
2
Blood-Brain Barrier Disruption in Neuroimmunological Disease.神经免疫性疾病中的血脑屏障破坏。
Int J Mol Sci. 2024 Oct 2;25(19):10625. doi: 10.3390/ijms251910625.
3
Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion.
血清蛋白质组学可区分 NMOSD 和 MOGA 相关疾病的亚型,并突出 B 细胞耗竭的作用。
Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200268. doi: 10.1212/NXI.0000000000200268. Epub 2024 Jun 17.
4
Circulating Autoantibody Profiling Identifies LIMS1 as a Potential Target for Pathogenic Autoimmunity in pathologic Myopia.循环自身抗体谱分析鉴定 LIMS1 为病理性近视中潜在的致病性自身免疫靶点。
Mol Cell Proteomics. 2024 Jun;23(6):100783. doi: 10.1016/j.mcpro.2024.100783. Epub 2024 May 9.
5
Serum LDL Promotes Microglial Activation and Exacerbates Demyelinating Injury in Neuromyelitis Optica Spectrum Disorder.血清 LDL 促进小胶质细胞活化并加重视神经脊髓炎谱系疾病的脱髓鞘损伤。
Neurosci Bull. 2024 Aug;40(8):1104-1114. doi: 10.1007/s12264-023-01166-y. Epub 2024 Jan 16.
6
Understanding the Pathophysiology and Magnetic Resonance Imaging of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.了解多发性硬化症和视神经脊髓炎谱系疾病的病理生理学和磁共振成像。
Korean J Radiol. 2023 Dec;24(12):1260-1283. doi: 10.3348/kjr.2023.0360.
7
Combined platelet-to-lymphocyte ratio and blood-brain barrier biomarkers as indicators of disability in acute neuromyelitis optica spectrum disorder.联合血小板与淋巴细胞比值和血脑屏障生物标志物作为急性视神经脊髓炎谱系疾病残疾的指标。
Neurol Sci. 2024 Feb;45(2):709-718. doi: 10.1007/s10072-023-07058-3. Epub 2023 Sep 7.
8
Physiological Roles of the Autoantibodies to the 78-Kilodalton Glucose-Regulated Protein (GRP78) in Cancer and Autoimmune Diseases.抗78千道尔顿葡萄糖调节蛋白(GRP78)自身抗体在癌症和自身免疫性疾病中的生理作用
Biomedicines. 2022 May 24;10(6):1222. doi: 10.3390/biomedicines10061222.
9
Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.血脑屏障:转运模型的新趋势及针对神经疾病治疗干预的新时代策略
Mol Brain. 2022 Jun 1;15(1):49. doi: 10.1186/s13041-022-00937-4.
10
GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder.GRP78 抗体与抗髓鞘少突胶质细胞糖蛋白抗体相关疾病中的血脑屏障破坏有关。
Neurol Neuroimmunol Neuroinflamm. 2021 Nov 1;9(1). doi: 10.1212/NXI.0000000000001038. Print 2022 Jan.